ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00332176
Recruitment Status : Unknown
Verified April 2008 by BioWest Therapeutics Inc.
Recruitment status was:  Recruiting
First Posted : June 1, 2006
Last Update Posted : April 8, 2008
Sponsor:
Information provided by:
BioWest Therapeutics Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2008
  Estimated Study Completion Date : December 2008